Schedule 13G ownership disclosure

RECURSION PHARMACEUTICALS INC CL A

Class A Common Stock · CUSIP: 75629V104

Event date: 2025-12-31

Filing-level shares
23,774,972.00
Percent of class
4.6%
  • BAILLIE GIFFORD & CO

    Shares: 23,774,972.00 · Class: 4.6%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001088875-26-000005
Form type
SCHEDULE 13G/A
Filer
BAILLIE GIFFORD & CO
CIK
CIK 1088875
Filed
Feb 05, 2026
Reporting period
Dec 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub